Skip to content
value.today

Flagship Biosciences, Inc.

Formerly Flagship Biosciences, LLC

Total raised
$12 M
4 rounds on record
Latest round
$5 M
Apr 2024
First round on record
Jan 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Flagship Biosciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2024$5 MNo. 4$2 to $10 million

Flagship Biosciences, Inc.: Raise no. 4, Apr 2024

Investors in this round

3 investors had bought by the notice of Apr 18, 2024: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Tom Turi · Executive Officer, Director
  • Trevor Johnson · Executive Officer, Director
  • Herb Hooper · Director
  • Paul Kirchgraber · Director
  • William Snider · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Trevor Johnson, Ceo. Source: SEC Form D, newest notice filed Apr 18, 2024. Read the notice at the SEC.

equitySEC
Nov 2023$3 MNo. 3$2 to $10 million

Flagship Biosciences, Inc.: Raise no. 3, Nov 2023

Investors in this round

3 investors had bought by the notice of Feb 21, 2024: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Convertible Promissory Notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Trevor Johnson · Executive Officer, Director
  • Herb Hooper · Director
  • Paul Kirchgraber · Director
  • Tom Turi · Director
  • William Snider · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Trevor Johnson, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Feb 21, 2024. Read the notice at the SEC.

debt, optionsSEC
Aug 2022$15 MIssued in a merger or acquisition$10 to $50 million

Flagship Biosciences, Inc.: Private sale, Aug 2022

Investors in this round

3 investors had bought by the notice of Sep 9, 2022: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Trevor Johnson · Executive Officer, Director
  • Bill H. Snider · Director
  • Fisher Aaron · Director
  • Herb H. Hooper · Director
  • Tom H. Turi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Trevor Johnson, CEO and President. Source: SEC Form D, newest notice filed Sep 9, 2022. Read the notice at the SEC.

equitySEC
Jun 2018$3 MNo. 2$2 to $10 million

Flagship Biosciences, Inc.: Raise no. 2, Jun 2018

Investors in this round

10 investors had bought by the notice of Jul 9, 2018: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • G. David Young · Executive Officer, Director, Promoter
  • Holger Dean Lange · Executive Officer
  • Joe Dean Kruger · Executive Officer
  • L. Dean Northey · Executive Officer
  • Trevor Johnson · Executive Officer, Director, Promoter
  • Gary Dean Clark · Director
  • Nancy Dean Gillett · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by L. Dean Northey, CFO, Secretary, Treasurer. Source: SEC Form D, newest notice filed Jul 9, 2018. Read the notice at the SEC.

equitySEC
Jan 2018$1 MNo. 1Under $2 million

Flagship Biosciences, Inc.: Raise no. 1, Jan 2018

Investors in this round

9 investors had bought by the notice of Mar 16, 2018: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dean David Northey · Executive Officer
  • G. David Young · Executive Officer, Director, Promoter
  • Trevor Johnson · Executive Officer, Director, Promoter
  • Gary M. Clark · Director
  • Gregory K. Tucker · Director
  • Nancy A. Gillett · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds of the offering shall be maintained in a separate bank account. Some of the proceeds may be used for general working capital purposes which may include payment of salaries, expenses and fees to those listed in Item 3.”

Signed by Dean Northey, Chief Financial Officer, Secretary,Treasurer. Source: SEC Form D, newest notice filed Mar 16, 2018. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Flagship Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2024).

    SEC Form D · Apr 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2024

That is all the official record says: Flagship Biosciences, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Flagship Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Flagship Biosciences, Inc.
NameRoleNamed in
Tom TuriExecutive officerApr 2024
Trevor JohnsonExecutive officerApr 2024
G. David YoungExecutive officerJul 2018
Holger Dean LangeExecutive officerJul 2018
Joe Dean KrugerExecutive officerJul 2018
L. Dean NortheyExecutive officerJul 2018
Dean David NortheyExecutive officerMar 2018
Herb HooperDirectorApr 2024
Paul KirchgraberDirectorApr 2024
Tom TuriDirectorApr 2024
Trevor JohnsonDirectorApr 2024
William SniderDirectorApr 2024
Bill H. SniderDirectorSep 2022
Fisher AaronDirectorSep 2022
Herb H. HooperDirectorSep 2022
Tom H. TuriDirectorSep 2022
G. David YoungDirectorJul 2018
Gary Dean ClarkDirectorJul 2018
Nancy Dean GillettDirectorJul 2018
Gary M. ClarkDirectorMar 2018
Gregory K. TuckerDirectorMar 2018
Nancy A. GillettDirectorMar 2018
G. David YoungPromoterJul 2018
Trevor JohnsonPromoterJul 2018